Literature DB >> 450229

Heterotransplantation of human craniopharyngiomas in athymic "nude" mice.

D E Bullard, D D Bigner.   

Abstract

Surgical biopsies from 2 human craniopharyngiomas were transplanted subcutaneously into 6 athymic "nude" mice. Morphologically characteristic craniopharyngiomas grew in 5 of these animals. In 4 animals growth was sufficient to allow transplantation into a second generation of animals. In all, 11 craniopharyngiomas were present at autopsy in the 14 animals into which the tumors had been transplanted. The tumors that grew in the animals had the same adamantinomatous architecture, epithelial nests, and keratinized nodules that were present in the original surgical sample and that are characteristic of human craniopharyngiomas. It may be possible to study growth characteristics and therapeutic sensitivities of human craniopharygniomas growing in "nude" mice.

Entities:  

Mesh:

Year:  1979        PMID: 450229     DOI: 10.1227/00006123-197904000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.

Authors:  H S Friedman; P C Burger; S H Bigner; J Q Trojanowski; G M Brodeur; X M He; C J Wikstrand; J Kurtzberg; M E Berens; E C Halperin
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

2.  Busulfan therapy of central nervous system xenografts in athymic mice.

Authors:  R H Aaron; G B Elion; O M Colvin; M Graham; S Keir; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Activity of VNP40101M (Cloretazine) in the treatment of CNS tumor xenografts in athymic mice.

Authors:  Michael A Badruddoja; Stephen T Keir; Ivan King; Joseph Zeidner; James J Vredenburgh; Lawrence H Muhlbaier; Darell D Bigner; Henry S Friedman
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

Review 4.  Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology.

Authors:  John Richard Apps; Juan Pedro Martinez-Barbera
Journal:  Brain Pathol       Date:  2017-05       Impact factor: 6.508

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.